13F-HR filed by Stonepine Capital Management, LLC
Stonepine Capital Management, LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 20 holding rows worth $126,057,631.
- Accession
- 0000935836-24-000386
- Filer
- CIK 1440771
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 20 entries on the cover page, a total value of $126,057,631 stated on the cover page (in dollars after the unit check, H1), rows summing to $126,057,631 with VALUE read as dollars as filed, 13F file number 028-17175. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EVOLUS INC | 30052C107 | COM | 2,674,356 | $37,440,984 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 3,426,882 | $22,617,421 | dollars as filed | |
| ALIMERA SCIENCES INC | 016259202 | COM | 4,051,072 | $15,799,181 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 393,634 | $12,675,015 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 1,976,342 | $9,723,603 | dollars as filed | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 253,770 | $6,103,169 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 688,200 | $3,902,094 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 3,480,409 | $3,251,398 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 1,462,296 | $2,617,510 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 446,776 | $2,242,816 | dollars as filed | |
| CALCIMEDICA INC | 38942Q202 | COM NEW | 522,602 | $2,174,024 | dollars as filed | |
| ANIKA THERAPEUTICS INC | 035255108 | COM | 60,949 | $1,548,105 | dollars as filed | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 1,040,241 | $1,539,557 | dollars as filed | |
| AYTU BIOPHARMA INC | 054754858 | COM | 472,469 | $1,436,306 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 598,086 | $1,321,770 | dollars as filed | |
| EXAGEN INC | 30068X103 | COM | 384,600 | $611,514 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 141,548 | $332,638 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 121,479 | $309,771 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 156,167 | $270,169 | dollars as filed | |
| SCYNEXIS INC | 811292200 | COM NEW | 95,637 | $140,586 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000935836-24-000386 | this filing | 2024-05-15 | acceptance time not in the bulk data set |